Clinical Trials in the U.S. and China
With fully integrated operations to advance your drug development program,
Frontage offers Phase I through Phase IIa, and Phase IV clinical trials and services in the U.S. plus Phase I-IV clinical trials and services in China. These services include:
Frontage clinical research and biometrics professionals have a successful track record of executing and managing Phase I-IV trials in both North America and China. We operate an 88-bed state-of-the-art clinical research center in Hackensack, NJ, and 3 China SFDA certified, hospital-based clinical research centers in China (First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Jilin University, and First Affiliated Hospital of Nanjing Medical University).
Our experienced biometrics associates in the US and China provide services including data management (with EDC capability), statistical consulting, programming and analysis, CDISC data mapping and conversion, and medical writing. In addition, our dedicated full time clinical pharmacologists have a range of capabilities -- from simple PK parameter calculations to pharmacokinetic modeling and/or simulations for your needs. And our dedicated pharmacovigilance associates can help you in SAE tracking and reporting, MedDRA coding, and MedWatch Form preparation. At Frontage, you will get cost-effective and integrated services for all your clinical development needs.